The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee is an almefene hydrochloride nasal spray that is the first of its kind ...

The FDA has approved Opvee as the first nalmefene hydrochloride prescription nasal spray to reverse opioid overdose in adults and children aged 12 years and older, according to a press release ...

U.S. health regulators have approved a new nasal spray to reverse overdoses due to fentanyl and other powerful opioids. Those drugs are currently the driving force behind the country's ongoing ...

U.S. health regulators have approved a new nasal spray to reverse overdoses due to fentanyl and other powerful ... The drug will be available via prescription and is approved for patients 12 and ...

WASHINGTON (AP) — U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

The nasal spray — which includes updated instructions for regular users — is expected to launch this summer. Emergent Biosolutions hasn’t yet announced a price for the over-the-counter version.

WASHINGTON (AP) — U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis. Opvee ...

WASHINGTON (AP) — U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis. Opvee ...

WASHINGTON (AP) — U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl and other opioids driving the nation’s drug crisis ...